In our analysis, ALT values did not show statistically significant differences between groups in the first days; however, from day 7, a progressive and statistically significant increase was observed in the A-ROP group (p = 0.001), a trend that persisted throughout the monitoring period. The gene discussed is GPT; the disease is retinopathy of prematurity.